KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Change in Account Payables (2016 - 2025)

Jazz Pharmaceuticals has reported Change in Account Payables over the past 16 years, most recently at -$29.0 million for Q4 2025.

  • Quarterly results put Change in Account Payables at -$29.0 million for Q4 2025, down 824.15% from a year ago — trailing twelve months through Dec 2025 was $39.9 million (up 298.53% YoY), and the annual figure for FY2025 was $39.9 million, up 298.53%.
  • Change in Account Payables for Q4 2025 was -$29.0 million at Jazz Pharmaceuticals, down from $62.4 million in the prior quarter.
  • Over the last five years, Change in Account Payables for JAZZ hit a ceiling of $62.4 million in Q3 2025 and a floor of -$32.0 million in Q2 2021.
  • Median Change in Account Payables over the past 5 years was -$1.6 million (2021), compared with a mean of $3.8 million.
  • Biggest five-year swings in Change in Account Payables: surged 20493.66% in 2022 and later plummeted 1042.52% in 2023.
  • Jazz Pharmaceuticals' Change in Account Payables stood at $37.9 million in 2021, then tumbled by 140.72% to -$15.4 million in 2022, then soared by 47.43% to -$8.1 million in 2023, then surged by 61.31% to -$3.1 million in 2024, then plummeted by 824.15% to -$29.0 million in 2025.
  • The last three reported values for Change in Account Payables were -$29.0 million (Q4 2025), $62.4 million (Q3 2025), and -$12.7 million (Q2 2025) per Business Quant data.